To include your compound in the COVID-19 Resource Center, submit it here.

Asieris raises series B round

Asieris Pharmaceuticals Co. Ltd. (Taizhou, China) said it raised RMB110-RMB120 million

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE